For Immediate Release Chicago, IL – May 02, 2017 – Today, Zacks Investment Ideas feature highlights Features: Tesla (NASDAQ: TSLA – Free Report ), Pfizer (NYSE: PFE – Free Report ), Apple (NASDAQ: AAPL – Free Report ) and Facebook (NASDAQ: FB – Free Report ). The Week Ahead in One Click This is going to be a deciding week for investors that normally adhere to the “Sell in May and Go Away” thesis. The market has not only been strong in the moves higher, it has also been resilient in the face of recent downturns. Big Data Points We are not wasting any time this month, with ISM Manufacturing coming out on the first day. Another important data point that has been key to the Trump Trade is construction spending. Both data points come out at 10 AM EST. Tuesday has new vehicle sales which have been slumping of late. The April reading 16.6M was the third month in a row coming in under the estimate. The other readings were only 300K and 100K below the expectation, but in April the miss was 800K. Expectations have rebounded to 17.1M which would be a nice increase. There is another automotive event later this week, but I want to review the Tesla (NASDAQ: TSLA – Free Report ) numbers in detail. Wednesday kicks off with the ADP employment change, which some market participants really like. I, however, only see the recent wild misses and completely discount this metric at the current time. Much more importantly is the ISM Non-Manufacturing number that comes out at 10 AM EST. The metric last month came in well below expectations yet the market was able to gain roughly 1% in the month. This metric, probably more than any other will determine if there is a wide scale “sell in May” movement. Thursday has some unemployment claims numbers, but they will just be a tease for Friday. Expect Thursday to be somewhat slow in terms of market movement as the ISM numbers are digested and traders get positioned before the BLS Jobs number comes on Friday. The consensus is calling for a gain of 194K jobs, which would be a significant increase from the 98K reported last month but there could be some big revisions. https://twitter.com/bbolan1!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs"); Earnings Season Earnings season has been pretty good so far with earnings up 10% from the year ago period and 75% are beating estimates. Just as importantly about 64% are beating revenue expectations with about 40% of the S&P 500 having reported already. Tuesday has several large players reporting in the morning with healthcare taking center stage, Pfizer (NYSE: PFE – Free Report ) among them. After the close we will be watching Apple (NASDAQ:AAPL – Free Report ) but given that most are looking forward to the launch of the next iPhone. Wednesday after the close, we have the big reports coming fromFacebook (NASDAQ: FB – Free Report ) and Tesla. I mentioned TSLA already as get new vehicle sales a day earlier, but this could be a huge report. The stock is a Zacks Rank #2 (Buy) and has been powering higher ever since the company beat delivery numbers for 1Q which was announced on March 1. Even the biggest of bears, Barclays which has a sell rating and $165 price target, said that earnings could be the start of another leg higher. Thursdays during earnings season are the heaviest days and this one is no exception. That will make trading on a “jobs” Friday morning that much more important. Friday has a few names in the morning and then we reload and do it all again next week. Quiet Period There is one quiet period of note coming to a close this week. OKTA will probably get some new reports from the brokerages that were on the deal team. A quick scan shows that the big boys and girls were on this deal so look for some good follow through buying in the name this week. Be sure to follow me on https://twitter.com/bbolan1!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs"); Want more articles from this author? Go to Zacks.com on this article and click the FOLLOW AUTHOR button to get an email each time a new article is published. Brian Bolan is a Stock Strategist for Zacks.com. He runs Stocks Under $10 Investor service where he looks for low priced stocks that are seeing positive earnings estimate revisions. This popular service has seen some strong early returns and offers a free trial via the Zacks Ultimate service. Brian also runs the brand new Zacks Game Changers where he looks for stocks that are disrupting their industries and reaping big gains. Looking for Ideas with Even Greater Upside? Today's investment ideas are short-term, directly based on our proven 1 to 3 month indicator. In addition, I invite you to consider our long-term opportunities. These rare trades look to start fast with strong Zacks Ranks, but carry through with double and triple-digit profit potential. Starting now, you can look inside our home run, value, and stocks under $10 portfolios, plus more. Click here for a peek at this private information>> Get the full Report on TSLA – FREE Get the full Report on AAPL – FREE Get the full Report on PFE – FREE Get the full Report on FB – FREE Follow us on Twitter: https://twitter.com/ZacksResearch!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs");"> https://twitter.com/ZacksResearch!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs"); Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Media Contact Zacks Investment Research 800-767-3771 ext. 9339 support@zacks.com https://www.zacks.com/performance Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tesla Inc. (TSLA): Free Stock Analysis Report Pfizer, Inc. (PFE): Free Stock Analysis Report Apple Inc. (AAPL): Free Stock Analysis Report Facebook, Inc. (FB): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research